Browse related articlesAmphetamine use on rise in KSA
United Arab Emirates: Thursday, July 03 - 2008 at 08:32
Seizures of amphetamines have risen sharply in Saudi Arabia, signaling a surge in consumption of the illegal stimulant in the kingdom, according to a report by the United Nations Office on Drugs and Crime. Saudi Arabia accounted for 28% of all global amphetamine seizures in 2006, the latest year for which data are available. The quantities impounded in the kingdom started to rise sharply in 2004 and reached 12.3 tonnes in 2006, reported the UK's Financial Times.
See Also
Also consider reading:
- » New lab to test drugs in UAE
- » UAE hospitals get international accreditation
- » New medical tests for UAE expats
- » UAE hospital to note heat cases
- » Rashid Trauma Centre 'overbooked'
- » New standard defines tomatoes
- » UAE's Hepatitis C patients in limbo
- » Saudi healthcare to focus on clinics
- » Cervical cancer awareness drive in UAE
- » UAE opens clinic in remote area
Facebook
LinkedIn
Digg
Jeff Florian, Senior ReporterThursday, July 03 - 2008 at 08:32 UAE local time (GMT+4)
Replication or redistribution in whole or in part is expressly prohibited without the prior written consent of AME Info FZ LLC / Emap Limited.
Disclaimer:
The information comprised in this section is not, nor is it held out to be, a solicitation of any person to take any form of investment decision. The content of the AME Info Web site does not constitute advice or a recommendation by AME Info FZ LLC / Emap Limited and should not be relied upon in making (or refraining from making) any decision relating to investments or any other matter. You should consult your own independent financial adviser and obtain professional advice before exercising any investment decisions or choices based on information featured in this AME Info Web site.
AME Info FZ LLC / Emap Limited can not be held liable or responsible in any way for any opinions, suggestions, recommendations or comments made by any of the contributors to the various columns on the AME Info Web site nor do opinions of contributors necessarily reflect those of AME Info FZ LLC / Emap Limited.
In no event shall AME Info FZ LLC / Emap Limited be liable for any damages whatsoever, including, without limitation, direct, special, indirect, consequential, or incidental damages, or damages for lost profits, loss of revenue, or loss of use, arising out of or related to the AME Info Web site or the information contained in it, whether such damages arise in contract, negligence, tort, under statute, in equity, at law or otherwise.
The information comprised in this section is not, nor is it held out to be, a solicitation of any person to take any form of investment decision. The content of the AME Info Web site does not constitute advice or a recommendation by AME Info FZ LLC / Emap Limited and should not be relied upon in making (or refraining from making) any decision relating to investments or any other matter. You should consult your own independent financial adviser and obtain professional advice before exercising any investment decisions or choices based on information featured in this AME Info Web site.
AME Info FZ LLC / Emap Limited can not be held liable or responsible in any way for any opinions, suggestions, recommendations or comments made by any of the contributors to the various columns on the AME Info Web site nor do opinions of contributors necessarily reflect those of AME Info FZ LLC / Emap Limited.
In no event shall AME Info FZ LLC / Emap Limited be liable for any damages whatsoever, including, without limitation, direct, special, indirect, consequential, or incidental damages, or damages for lost profits, loss of revenue, or loss of use, arising out of or related to the AME Info Web site or the information contained in it, whether such damages arise in contract, negligence, tort, under statute, in equity, at law or otherwise.
Web Feeds